3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
66
Pancreatic Neoplasms
35
Neuroblastoma
21
Neoplasm Metastasis
21
Neoplasms
16
Colonic Neoplasms
15
Stomach Neoplasms
14
Rectal Neoplasms
13
Esophageal Squamous Cell Carcinoma
9
Sarcoma, Ewing
8
Rhabdomyosarcoma
8
Small Cell Lung Carcinoma
7
Sarcoma
7
Ovarian Neoplasms
6
Lung Neoplasms
6
Cholangiocarcinoma
6
Esophageal Neoplasms
5
Breast Neoplasms
5
Adenocarcinoma Of Esophagus
5
Medulloblastoma
4
Endometrial Neoplasms
4
Biliary Tract Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Osteosarcoma
3
Locally Advanced Rectal Cancer
3
Glioma
3
Glioblastoma
3
Gastrointestinal Neoplasms
3
Interventions
apatinib
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrectomy
2
trastuzumab deruxtecan
1
taxane
1
sintilimab
1
pembrolizumab
1
durvalumab
1
disitamab vedotin
1
cabozantinib
1
Taxes
1
Tadalafil
1
SHR-1701
1
S 1 (combination)
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Indocyanine Green
1
Immunotherapy, Adoptive
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastric Adenocarcinoma
×
Irinotecan
×
1 year
×
Clear all
No trials found.